Star Sports Med (01609) announced that it spent HK$1.2746 million to repurchase 10,600 shares on September 8, 2026, with the buyback price ranging from HK$119 to HK$121.2 per share.
The repurchase reflects the company's ongoing capital management strategy, as it continues to return value to shareholders through share buybacks in the open market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.